Clinical Trial Update: Vaccination With Flt3L, Radiation, and Poly-ICLC [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating vaccination with Flt3L, radiation, and Poly-ICLC in cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Head and Neck Squamous Cell Carcinoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Flt3 ligand (Flt3L) (Flt3L)
• Poly-ICLC (poly-ICLC)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Non-Hodgkin's Lymphoma, Metastatic Breast Cancer | Phase 1, Phase 2 | Status: UNKNOWN